Invenio Imaging
Founded Year
2012Stage
Series A - III | AliveTotal Raised
$7.75MLast Raised
$3.04M | 2 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+60 points in the past 30 days
About Invenio Imaging
Invenio is dedicated to developing a fast, reliable, simple-to-use technology for non-destructive microscopic analysis of the molecular make-up of tissues and other materials. Invenio's platform technology is positioned to enter the R&D microscopy market, and it is developing instrumentation for several high-value medical applications.
Invenio Imaging's Product Videos
Compete with Invenio Imaging?
Ensure that your company and products are accurately represented on our platform.
Invenio Imaging's Products & Differentiators
NIO Laser Imaging System
The NIO uses Stimulated Raman Histology to provide microscopic images of fresh tissue specimens in minutes. Digital images can be sent for immediate review by pathology allowing for closer collaboration between surgery and pathology. The NIO has now been used in over 2000 cases at sites across the United States and in Europe.
Expert Collections containing Invenio Imaging
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Invenio Imaging is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Invenio Imaging Patents
Invenio Imaging has filed 6 patents.
The 3 most popular patent topics include:
- Medical imaging
- Oncology
- Spectroscopy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/14/2020 | 8/23/2022 | Brain tumor, Spectroscopy, Rare cancers, Oncology, Anatomical pathology | Grant |
Application Date | 8/14/2020 |
|---|---|
Grant Date | 8/23/2022 |
Title | |
Related Topics | Brain tumor, Spectroscopy, Rare cancers, Oncology, Anatomical pathology |
Status | Grant |
Latest Invenio Imaging News
Jan 4, 2023
News provided by Share this article Share this article SANTA CLARA, Calif., Jan. 4, 2023 /PRNewswire/ -- Invenio Imaging, Inc., a leader in intraoperative fresh tissue imaging and artificial intelligence, today announced that it has entered into a research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson* to develop and validate the NIO® Lung Cancer Reveal image analysis algorithm to assist physicians in the evaluation of bronchoscopic lung biopsies. The NIO® Laser Imaging Systems allows rapid imaging of fresh tissue biopsies with subcellular resolution in the procedure room with minimal preparation while preserving the sample for additional downstream pathology analysis. "In this important clinical study, we will develop a novel image analysis algorithm based on machine learning to provide physicians with real-time feedback determining whether a biopsy sample contains cancer", says Chris Freudiger, PhD, Co-Founder and CTO of Invenio Imaging. "We are excited to undertake this ambitious clinical study in collaboration with the Lung Cancer Initiative" "We are excited to undertake this ambitious clinical study in collaboration with the Lung Cancer Initiative", says Jay Trautman, PhD, Co-Founder and CEO of Invenio Imaging. NIO® Lung Cancer Reveal has not been cleared by the Food and Drug Administration for clinical use in the United States. About Invenio Imaging Inc. Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of cancer patients by combining intraoperative fresh tissue imaging with artificial intelligence. Our technology, the NIO Laser Imaging System, has been used in over 3000 procedures at major cancer centers in the US and in Europe. In 2021 Invenio received a Medical Design Excellence Award, was selected to be a Rosenman Innovator, and received CE Mark to commercialize in Europe. www.nioimaging.com . *The legal entity of the Lung Cancer Initiative at Johnson & Johnson is Johnson & Johnson Enterprise Innovation, Inc.
Invenio Imaging Frequently Asked Questions (FAQ)
When was Invenio Imaging founded?
Invenio Imaging was founded in 2012.
Where is Invenio Imaging's headquarters?
Invenio Imaging's headquarters is located at 2310 Walsh Ave, Santa Clara.
What is Invenio Imaging's latest funding round?
Invenio Imaging's latest funding round is Series A - III.
How much did Invenio Imaging raise?
Invenio Imaging raised a total of $7.75M.
Who are the investors of Invenio Imaging?
Investors of Invenio Imaging include Mission Bay Capital and Paycheck Protection Program.
Who are Invenio Imaging's competitors?
Competitors of Invenio Imaging include Zeiss.
What products does Invenio Imaging offer?
Invenio Imaging's products include NIO Laser Imaging System.
Who are Invenio Imaging's customers?
Customers of Invenio Imaging include Michigan Health, NYU Langone Health, Hoag Hospital, Dayton Children's Hospital and UCSF.
Compare Invenio Imaging to Competitors
Oivi focuses on early detection of Diabetic Retinopathy. Oivi aims to prevent blindness among diabetes patients by deploying an AI-camera for automated retinal disease diagnostics.
Delmic creates high-performance correlative light and electron microscopy and cathodoluminescence solutions for the life sciences and materials science.
Helmee Imaging is a company that provides CSD systems for visual quality inspection for glossy, mirror-like parts. It automates the inspection of high gloss surfaces, such as chrome-plated, PVD-coated, painted, or polished plastics and metals. The automotive industry is the company's main market area, but its CSD technology enables it to operate in business fields with the need for high gloss surfaces, such as sanitary goods or common household items. Helmee Imaging was founded in 2013 and is based in Tampere, Finland.
Zeiss is a German manufacturer of optical systems and optoelectronics. Its products range from medical technology, microscopy, vision care, cinematography, and more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.